Skip to main content
Top
Published in: Intensive Care Medicine 3/2016

01-03-2016 | Focus Editorial

Focus on immunocompromised patients

Authors: Elie Azoulay, Marcio Soares, Dominique Benoit

Published in: Intensive Care Medicine | Issue 3/2016

Login to get access

Excerpt

Immunocompromised patients represent a growing proportion of critically ill patients [1]. These patients do not have the ability to respond normally to an infection due to an impaired or weakened immune system. This inability to fight infection can be caused by a number of conditions including underlying disease (malignancy, organ or stem cell transplantation, systemic vasculitis, connective tissues diseases, etc.), associated conditions (diabetes, malnutrition, etc.) or drug-related immune suppression. Immunocompromised patients are admitted for life-threatening complications related to the underlying condition, severe infections, or severe toxic events. Also, because of the ageing population, immunocompromised patients may also be admitted for acute medical conditions unrelated to immune suppression. In the present editorial, we sought to focus on the studies published on immunocompromised patients and comment on how much they have added to the existing literature. …
Literature
1.
2.
go back to reference Lehrnbecher T, Koehl U, Wittekindt B et al (2008) Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol 9:269–278. doi:10.1016/S1470-2045(08)70071-8 CrossRef Lehrnbecher T, Koehl U, Wittekindt B et al (2008) Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol 9:269–278. doi:10.​1016/​S1470-2045(08)70071-8 CrossRef
3.
go back to reference Zinter MS, DuBois SG, Spicer A et al (2014) Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 40:1536–1544. doi:10.1007/s00134-014-3389-2 CrossRef Zinter MS, DuBois SG, Spicer A et al (2014) Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit. Intensive Care Med 40:1536–1544. doi:10.​1007/​s00134-014-3389-2 CrossRef
4.
go back to reference Rieger C, Barlow S, Maschmeyer G (2014) What’s new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates? Intensive Care Med 40:1549–1552. doi:10.1007/s00134-014-3368-7 CrossRef Rieger C, Barlow S, Maschmeyer G (2014) What’s new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates? Intensive Care Med 40:1549–1552. doi:10.​1007/​s00134-014-3368-7 CrossRef
5.
go back to reference Maschmeyer G, Carratalà J, Buchheidt D et al (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26:21–33. doi:10.1093/annonc/mdu192 CrossRef Maschmeyer G, Carratalà J, Buchheidt D et al (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26:21–33. doi:10.​1093/​annonc/​mdu192 CrossRef
7.
go back to reference Mokart D, Slehofer G, Lambert J et al (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49. doi:10.1007/s00134-013-3148-9 CrossRef Mokart D, Slehofer G, Lambert J et al (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49. doi:10.​1007/​s00134-013-3148-9 CrossRef
9.
10.
11.
16.
go back to reference van Vliet M, Verburg IWM, van den Boogaard M et al (2014) Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med 40:1275–1284. doi:10.1007/s00134-014-3373-x CrossRef van Vliet M, Verburg IWM, van den Boogaard M et al (2014) Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med 40:1275–1284. doi:10.​1007/​s00134-014-3373-x CrossRef
19.
go back to reference Barbier F, Roux A, Canet E et al (2014) Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France. Intensive Care Med 40:1906–1915. doi:10.1007/s00134-014-3481-7 CrossRef Barbier F, Roux A, Canet E et al (2014) Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France. Intensive Care Med 40:1906–1915. doi:10.​1007/​s00134-014-3481-7 CrossRef
Metadata
Title
Focus on immunocompromised patients
Authors
Elie Azoulay
Marcio Soares
Dominique Benoit
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 3/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4224-8

Other articles of this Issue 3/2016

Intensive Care Medicine 3/2016 Go to the issue

What's New in Intensive Care

What’s new in bacterial meningitis